Harvard Apparatus Regenerative Technology, Inc. (HRGN)
Data as of , from SEC Form 4 filings.
See up to 3 months of HRGN. The 7-day demo opens the 1M and 3M ranges and puts HRGN on your watchlist.
Start 7-day demoLatest HRGN insider trades
About Harvard Apparatus Regenerative Technology, Inc. (HRGN)
Harvard Apparatus Regenerative Technology, Inc. files with the SEC under CIK 0001563665 and is classified as surgical and medical instruments and apparatus. It is grouped with Health Care companies on this site.
HRGN Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 2 | 368,630 | $394K |
| Grant or award | 2 | 1,200,000 | |
| Other acquisition / disposition | 4 | 1,401,636 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
HRGN insider transactions (Form 4)
2613 Form 4 filings on record, the earliest from Jun 27, 2025, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Junli He - Officer | Other | Common Stock | 683,725 | $1.05 | $718K | |
| Junli He - Officer | Open-market purchase | Common Stock | 361,905 | $1.05 | $380K | |
| Junli He - Officer | Open-market purchase | Common Stock | 6,725 | $2.15 footnote F3 | $14K | |
| Junli He - Officer | Other | Bridge Note (04/14/2026) | 310,000 footnote F5 | - footnote F4 | - | |
| Junli He - Officer | Other | Bridge Note (05/13/2026) | 205,378 footnote F5 | - footnote F4 | - | |
| Junli He - Officer | Other | Bridge Note (07/16/2026) | 202,533 footnote F5 | - footnote F4 | - | |
| ||||||
| Junli He - Officer | Grant or award | Nonqualified Stock Option (right to buy), time-based tranche | 600,000 | $0.00 | - | |
| Junli He - Officer | Grant or award | Nonqualified Stock Option (right to buy), performance-based | 600,000 | $0.00 | - | |
| Junli He - Officer | Open-market purchase | Common Stock | 3,000 | $1.70 footnote F1 | $5K | |
| ||||||
| Junli He - Officer | Open-market purchase | Common Stock | 300 | $1.98 | $594 | |
| Junli He - Officer | Open-market purchase | Common Stock | 11,225 | $1.85 | $21K | |
| Junli He - Officer | Open-market purchase | Common Stock | 4,050 | $1.72 | $7K | |
| Mao Zhang - Director | Grant or award | Stock Option (right to buy) | 18,590 | $0.00 | - | |
| Mao Zhang - Director | Grant or award | Stock Option (right to buy) | 15,227 | $0.00 | - | |
| Herman Sanchez - Director | Grant or award | Stock Option (right to buy) | 18,590 | $0.00 | - | |
| Herman Sanchez - Director | Grant or award | Stock Option (right to buy) | 15,227 | $0.00 | - | |
| Ting Li - Director | Grant or award | Stock Option (right to buy) | 18,590 | $0.00 | - | |
| Ting Li - Director | Grant or award | Stock Option (right to buy) | 15,227 | $0.00 | - | |
| Jing Chen - Director | Grant or award | Stock Option (right to buy) | 18,590 | $0.00 | - | |
| Jing Chen - Director | Grant or award | Stock Option (right to buy) | 15,227 | $0.00 | - | |
| James E. Shmerling - Director | Grant or award | Stock Option (right to buy) | 18,590 | $0.00 | - | |
| James E. Shmerling - Director | Grant or award | Stock Option (right to buy) | 15,227 | $0.00 | - | |
| Ronald J. Packard - Director | Grant or award | Stock Option (right to buy) | 18,590 | $0.00 | - | |
| Ronald J. Packard - Director | Grant or award | Stock Option (right to buy) | 15,227 | $0.00 | - | |
| David Green - Director | Grant or award | Stock Option (right to buy) | 18,590 | $0.00 | - | |
| David Green - Director | Grant or award | Stock Option (right to buy) | 15,227 | $0.00 | - | |
HRGN insider trading FAQ
What is the latest insider trade for HRGN?
Harvard Apparatus Regenerative Technology, Inc. (HRGN) had 2 insider filings in the last 90 days, with the most recent on 2026-09-25. The full record for HRGN runs to 13 Form 4 filings, the earliest from 2025-06-27. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying HRGN stock?
2 insider purchases of HRGN were filed in the last 90 days, totaling $394K.
How many insiders are selling HRGN stock?
No insider sales of HRGN were filed in the last 90 days.
Where can I see HRGN SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects HRGN Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Junli He view on EDGAR
- - Junli He view on EDGAR
- - Junli He view on EDGAR
- - Junli He view on EDGAR
- - Junli He view on EDGAR
- - Junli He view on EDGAR
- - Mao Zhang view on EDGAR
- - Herman Sanchez view on EDGAR
- - Ting Li view on EDGAR
- - Jing Chen view on EDGAR
Related companies with recent insider activity
Learn more
- How to read insider buying signals
- What an open-market purchase by an insider can and cannot tell you.
- Insider activity in Health Care
- Where HRGN's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow HRGN with a 7-day demo
- HRGN on your watchlist
- Every HRGN Form 4 filing on record
- Up to 3 months of HRGN price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
